Franklin Biotechnology Discovery Fund

Average Annual Total Returns [further-information] As of 06/30/2020

Month EndAs of 06/30/2020 1 Yr 3 Yr 5 Yr 10 Yr Since InceptionInception 09/15/1997
Fund without Sales Charge (%) (NAV) 22.07 9.03 1.44 17.12 10.65
Fund with Sales Charge (%) (POP) 21.07 9.03 1.44 17.12 10.65
NASDAQ Biotechnology Index (%) 25.36 9.81 2.14 18.43 12.05
S&P 500 Index (%) 7.51 10.73 10.72 13.99 7.49
Quarter EndAs of 06/30/2020 1 Yr 3 Yr 5 Yr 10 Yr Since InceptionInception 09/15/1997
Fund without Sales Charge (%) (NAV) 22.07 9.03 1.44 17.12 10.65
Fund with Sales Charge (%) (POP) 21.07 9.03 1.44 17.12 10.65
NASDAQ Biotechnology Index (%) 25.36 9.81 2.14 18.43 12.05
S&P 500 Index (%) 7.51 10.73 10.72 13.99 7.49

Calendar Year Returns

2019 2018 2017 2016 2015 2014 2013
Fund without Sales Charge (%) (NAV) 33.83 -16.34 17.91 -17.75 4.71 32.95 67.44
Fund with Sales Charge (%) (POP) 32.83 -17.15 16.91 -18.54 3.75 31.95 66.44
NASDAQ Biotechnology Index (%) 24.41 -9.32 21.06 -21.68 11.42 34.32 65.97
S&P 500 Index (%) 31.49 -4.38 21.83 11.96 1.38 13.69 32.39

Cumulative Total Returns [further-information] As of 06/30/2020

Month EndAs of 06/30/2020 YTD 1 Yr 3 Yr 5 Yr 10 Yr Since Inception since 09/15/1997
Fund without Sales Charge (%) (NAV) 12.59 22.07 29.60 7.42 385.58 903.51
Fund with Sales Charge (%) (POP) 11.59 21.07 29.60 7.42 385.58 903.51
NASDAQ Biotechnology Index (%) 13.49 25.36 32.41 11.20 442.81 1,235.98
S&P 500 Index (%) -3.08 7.51 35.77 66.45 270.31 418.39
Quarter EndAs of 06/30/2020 YTD 1 Yr 3 Yr 5 Yr 10 Yr Since Inception since 09/15/1997
Fund without Sales Charge (%) (NAV) 12.59 22.07 29.60 7.42 385.58 903.51
Fund with Sales Charge (%) (POP) 11.59 21.07 29.60 7.42 385.58 903.51
NASDAQ Biotechnology Index (%) 13.49 25.36 32.41 11.20 442.81 1,235.98
S&P 500 Index (%) -3.08 7.51 35.77 66.45 270.31 418.39

After-Tax Average Annual Total Returns [further-information] As of 06/30/2020

Month EndAs of 06/30/2020 1 YR 3 YR 5 YR 10 YR
Fund without Sales Charge (%) (NAV) Before Shares Sold 19.48 7.59 -0.06 15.63
Fund without Sales Charge (%) (NAV) After Shares Sold 14.56 6.65 0.72 14.10
Fund with Sales Charge (%) (POP) Before Shares Sold 18.48 7.59 -0.06 15.63
Fund with Sales Charge (%) (POP) After Shares Sold 13.96 6.65 0.72 14.10
Quarter EndAs of 06/30/2020 1 YR 3 YR 5 YR 10 YR
Fund without Sales Charge (%) (NAV) Before Shares Sold 19.48 7.59 -0.06 15.63
Fund without Sales Charge (%) (NAV) After Shares Sold 14.56 6.65 0.72 14.10
Fund with Sales Charge (%) (POP) Before Shares Sold 18.48 7.59 -0.06 15.63
Fund with Sales Charge (%) (POP) After Shares Sold 13.96 6.65 0.72 14.10

SALES CHARGE, EXPENSES & FEES As of 09/01/2019 (updated annually)

Gross Expense Ratio 1.79%
Net Expense Ratio [further-information] 1.77%
Max Initial Sales Charge 0.00%
CDSC 1.00%

Volatility Measures [further-information] As of 06/30/2020 Updated Monthly, based on a 3-year period

Beta 1.03
Sharpe Ratio 0.31
Standard Deviation 23.74

Benchmarks

A benchmark is a comparable broad-based index that can be used to evaluate a fund's performance.

  • NASDAQ Biotechnology Index
  • S&P 500 Index